Literature DB >> 12624705

The treatment of ankylosing spondylitis.

K J Scalapino1, J C Davis.   

Abstract

Ankylosing spondylitis is an inflammatory disorder affecting the axial skeleton and periphery. Symptoms can often be debilitating. Current therapy for the disease include physical therapy, non-steroidal anti-inflammatory drugs (NSAIDS, anti-rheumatic disease modifying drugs (DMARDS), and the newly developed biologic agents targeting tumor necrosis factor alpha (TNF-alpha). This paper will provide a comprehensive review of these treatments which focusing on evidence based medicine for the daily clinical practice of rheumatology.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12624705     DOI： 10.1007/s102380300000

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN： 1591-8890            Impact factor:   3.984


  12 in total

1.  Statin therapy might be beneficial for patients with ankylosing spondylitis.

Authors:  J C van Denderen; M J L Peters; V P van Halm; I E van der Horst-Bruinsma; B A C Dijkmans; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2005-10-11       Impact factor: 19.103

2.  Peripheral and central mechanisms of fatigue in inflammatory and noninflammatory rheumatic diseases.

Authors:  Roland Staud
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

Review 3.  Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype?

Authors:  Kenneth G-J Ooi; Grazyna Galatowicz; Virginia L Calder; Susan L Lightman
Journal:  Clin Med Res       Date:  2006-12

4.  Hearing and cochlear function of patients with ankylosing spondylitis.

Authors:  Orhan Kemal Kahveci; Umit Secil Demirdal; Abidin Duran; Ali Altuntas; Vural Kavuncu; Erdogan Okur
Journal:  Clin Rheumatol       Date:  2012-04-17       Impact factor: 2.980

5.  The Turkish versions of the Bath Ankylosing Spondylitis and Dougados Functional Indices: reliability and validity.

Authors:  Altinay Goksel Karatepe; Yesim Akkoc; Servet Akar; Yesim Kirazli; Nurullah Akkoc
Journal:  Rheumatol Int       Date:  2004-07-10       Impact factor: 2.631

6.  Polymorphisms in the SAA1/2 gene are associated with carotid intima media thickness in healthy Han Chinese subjects: the Cardiovascular Risk Survey.

Authors:  Xiang Xie; Yi-Tong Ma; Yi-Ning Yang; Zhen-Yan Fu; Xiao-Mei Li; Ding Huang; Xiang Ma; Bang-Dang Chen; Fen Liu
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

7.  A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity.

Authors:  Yesim Akkoc; Altinay Goksel Karatepe; Servet Akar; Yesim Kirazli; Nurullah Akkoc
Journal:  Rheumatol Int       Date:  2004-01-17       Impact factor: 2.631

8.  LLLT for the management of patients with ankylosing spondylitis.

Authors:  D Stasinopoulos; K Papadopoulos; D Lamnisos; A Stergioulas
Journal:  Lasers Med Sci       Date:  2016-01-21       Impact factor: 3.161

9.  Symptomatic improvement in function and disease activity in a patient with ankylosing spondylitis utilizing a course of chiropractic therapy: a prospective case study.

Authors:  Susan M Rutherford; Cameron F Nicolson; Edward R Crowther
Journal:  J Can Chiropr Assoc       Date:  2005-06

10.  An evaluation of anti-TNF-alpha-therapy in patients with ankylosing spondylitis: imbalanced activation of NF kappa B subunits in lymphocytes and modulation of serum cortisol concentration.

Authors:  Martin Eggert; Ulrike Seeck; Marco Semmler; Ulrich Maass; Sabine Dietmann; Martin Schulz; Helmut Dotzlaw; Gunther Neeck
Journal:  Rheumatol Int       Date:  2007-01-23       Impact factor: 3.580
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.